Similar Papers

Paper Title
Journal
Date
Author
Presurgical platelet–lymphocyte ratio for prognosis in advanced hypopharyngeal squamous cell carcinoma in individuals undergoing radical resection
Hong Chen ... Xiaohui Shen
Acta Oto-Laryngologica | VOL. 141
Hong Chen, et. al.Hong Chen ... Xiaohui Shen
19 Apr 2021
Relevance between PD-L1 expression combined with tumor infiltrating lymphocytes and prognosis in advanced hypopharyngeal squamous cell carcinoma.
Takeharu Ono ... Koichi Azuma
Journal of Clinical Oncology | VOL. 35
Takeharu Ono, et. al.Takeharu Ono ... Koichi Azuma
20 May 2017
Efficacy of PD-1 inhibitors combined with nab-paclitaxel and cisplatin in the neoadjuvant treatment of locally advanced hypopharyngeal squamous cell carcinoma
Q Fang ... X K Liu
Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery | VOL. 59
Q Fang, et. al.Q Fang ... X K Liu
07 Jul 2024
OP067: Treatment outcomes in advanced hypopharngeal carcinoma. Organ preservation vs surgical modality
Sharankumar Shetty ... Vidhyadharan Sivakumar
Oral Oncology | VOL. 49
Sharankumar Shetty, et. al.Sharankumar Shetty ... Vidhyadharan Sivakumar
01 May 2013
View more papers

More From: Journal of Cranio-Maxillofacial Surgery

Paper Title
Journal
Date
Author
Editorial Board
-
Journal of Cranio-Maxillofacial Surgery | VOL. 53
--
01 Jan 2025
EACMFS Prizes & Awards
-
Journal of Cranio-Maxillofacial Surgery | VOL. 53
--
01 Jan 2025
Impact of different staging methods of lymph nodes metastases on prognosis in advanced hypopharyngeal squamous cell carcinoma
Tian Wang ... Chunping Wu
Journal of Cranio-Maxillofacial Surgery | VOL. -
Tian Wang, et. al.Tian Wang ... Chunping Wu
01 Jan 2025
Announcements
-
Journal of Cranio-Maxillofacial Surgery | VOL. 53
--
01 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.